Abstract:Background: At present, the commercial artificial small diameter (< 6 mm) vascular grafts are still unsatisfactory, due to poor biocompatibility and low long-term patency rate. Objective: This study was to design a novel tissue engineering blood vessel constructed by dog bone marrow derived endothelial progenitor cells and decellularized allogeneic vascular scaffolds. Design, time and setting: From December 2005 to December 2007, the experiment, a randomized control trial of cells an histopathology in vitro, was completed in the Affiliated Drum Tower Hospital of Nanjing University Medical School. Materials: The decellularized canine common carotids were obtained by a detergent-enzymatic procedure; Bone marrow mononuclear cells from mongrel adult dogs were isolated using density gradient centrifugation method and cultured in culture flasks coated with fibronectin. Subsequently, the expanded endothelial progenitor cells were seeded on the decellularized scaffolds, and then co-cultured in the self-made bioreactor to construct the tissue engineering blood vessels. Methods: Bilateral common carotid artery and lateral femoral artery in twenty dogs were all exposed. Three vascular segments from each dog were harvested and then randomly divided into three groups according to the transplant with the tissue engineering blood vessels, decellularized allogeneic vascular scaffolds or autogenous vein. Twenty vessels were implanted into the dogs of each group. Main outcome measures: Immunocytochemical staining was used to identify the cultured endothelial progenitor cells; After 6 months of transplantation, the grafts were retrieved for digital subtraction angiography, pathological test and scanning electron microscope examination. Results: Dog bone marrow mononuclear cells presented a cobblestone-like appearance at 10 days of the culture. The immunocytochemistry results were consistent with the phenotype of endothelial progenitor cells; After highly proliferative endothelial progenitor cells were seeded onto the decellularized scaffold for 10 days, seed cells attached well in the lumen of blood vessels; Six months after implantation, the tissue engineering blood vessels were 85% patent and autogenous vein grafts were 90 patent, which was superior to decellularized allogeneic vascular scaffolds (25%). Conclusion: This study provides a new strategy to develop a tissue engineering blood vessel with excellent biocompatibility and high patency rate by the co-culture of dog bone marrow derived endothelial progenitor cells with decellularized vascular scaffolds.

Tissue Engineering: Tissue Engineered Bio‐Blood‐Vessels Constructed Using a Tissue‐Specific Bioink and 3D Coaxial Cell Printing Technique: A Novel Therapy for Ischemic Disease (adv. Funct. Mater. 33/2017)

3D-Printed Tortuous Vessels with Photodissociable and Morphology-Controllable Ink.

Development of 3D-bioprinted artificial blood vessels loaded with rapamycin-nanoparticles for ischemic repair

3D-Printed Proangiogenic Patches of Photo-Crosslinked Gelatin and Polyurethane Hydrogels Laden with Vascular Cells for Treating Vascular Ischemic Diseases

Studies on the ontogeny of the mouse immune system. II. Immunoglobulin-producing cells.

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Directly Coaxial 3D Bioprinting of Large-Scale Vascularized Tissue Constructs.

A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology

Three-dimensional bioprinting of artificial blood vessel: Process, bioinks, and challenges

Thermo-sensitive Sacrificial Microsphere-based Bioink for Centimeter-scale Tissue with Angiogenesis

3D bioprinting microgels to construct implantable vascular tissue

Engineering gelatin-based alginate/carbon nanotubes blend bioink for direct 3D printing of vessel constructs

Modified ECM-Based Bioink for 3D Printing of Multi-Scale Vascular Networks

Direct 3D bioprinting of perfusable vascular constructs using a blend bioink

Three-dimensional printing and decellularized-extracellular-matrix based methods for advances in Artificial Blood Vessel fabrication: A Review

Stem‐Cell‐Based Small‐Diameter Blood Vessels with 3D Printing

Three dimensional (bio)printing of blood vessels: from vascularized tissues to functional arteries

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Freestanding vascular scaffolds engineered by direct 3D printing with Gt-Alg-MMT bioinks

Biologically Inspired Smart Release System Based on 3D Bioprinted Perfused Scaffold for Vascularized Tissue Regeneration

3D-bioprinted cell-laden blood vessel with dual drug delivery nanoparticles for advancing vascular regeneration